ANIP
ANI Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$71.20
−1.09%Leverage
- Debt / equity
- 0.55x
- Net debt / equity
- -0.05x
- Debt / assets
- 0.22x
- Debt / EBITDA
- 1.29x
- Net debt / EBITDA
- -0.12x
Liquidity & coverage
- Current ratio
- 2.91x
- Quick ratio
- 2.41x
- Cash ratio
- 1.33x
- Interest coverage
- 5.47x
- EBITDA / interest
- 9.33x
- Working capital
- $541.8M
Cash & dividend
- FCF / debt
- 0.48x
- Cash flow / debt
- 0.57x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026